SCHEMBL5287709

SCHEMBL5287709

O=C(O)CNc1cccc(Oc2ccccc2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.59
MAPK1 P28482 2/20 0.59
MITF O75030 1/20 0.59
POLB P06746 1/20 0.59
HTT P42858 1/20 0.59
FFAR1 O14842 4/20 0.57
GRK2 P25098 3/20 0.55
GRK3 P35626 3/20 0.55
HDAC3 O15379 1/20 0.55
HDAC4 P56524 1/20 0.55
HDAC1 Q13547 1/20 0.55
HDAC7 Q8WUI4 1/20 0.55
HDAC2 Q92769 1/20 0.55
HDAC10 Q969S8 1/20 0.55
HDAC11 Q96DB2 1/20 0.55
HDAC8 Q9BY41 1/20 0.55
HDAC6 Q9UBN7 1/20 0.55
HDAC9 Q9UKV0 1/20 0.55
HDAC5 Q9UQL6 1/20 0.55
GRK5 P34947 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5284916 0.90 GRK2 (0.57) ALDH1A1MAPK1MITFPOLBHTT
SCHEMBL5301594 0.90 GRK2 (0.57) ALDH1A1MAPK1MITFPOLBHTT
SCHEMBL8021547 0.86 ALDH1A1 (0.55) ALDH1A1MAPK1MITFPOLBHTT
SCHEMBL5282610 0.85 GRK2 (0.58) ALDH1A1MAPK1MITFPOLBHTT
SCHEMBL5413973 0.85 FFAR1 (0.51) ALDH1A1MAPK1MITFPOLBHTT
SCHEMBL5954356 0.84 FFAR1 (0.59) ALDH1A1HTTFFAR1HDAC3HDAC4
SCHEMBL10439096 0.84 MAPK1 (0.56) ALDH1A1MAPK1MITFPOLBHTT
SCHEMBL5285556 0.83 MTNR1A (0.61) MITFHTTGRK2GRK3GRK5
SCHEMBL340537 0.82 AKR1C3 (0.55) ALDH1A1LMNAMAPTAKR1C3
SCHEMBL5287947 0.81 FFAR1 (0.62) ALDH1A1FFAR1GRK2GRK3GRK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070135499-A1 Hydrazide compounds AERIE PHARMACEUTICALS, INC. (US) 2007-06-14 US disclosed
WO-2007008942-A2 PHENYLAMINO-ACETIC ACID [1-(PYRIDIN-4-YL)-METHYLIDENE]-HYDRAZIDE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS OF G PROTEIN-COUPLED RECEPTOR KINASES FOR THE TREATMENT OF EYE DISEASES AERIE PHARMACEUTICALS, INC. (US) 2007-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135499-A1 Hydrazide compounds GRK4, GRK2, GRK1 ALDH1A1 2861/4885MAPK1 852/4885MITF 327/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.